Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Big Pharma lost in court - Congress must not bail it out
For the last three years, some of the most profitable corporations in the world spent millions of dollars in court attempting to reverse the biggest defeat the pharmaceutical industry suffered in decades. The Supreme Court recently declined even to…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 24 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 10, 2026 –…
Stock to buy today: Ajanta Pharma (₹3,073) - BUY
The short-term outlook is bullish for Ajanta Pharma. The stock is moving in a bull channel since November last year. The recent bounce has happened from just above the lower end of the channel. The chances are high for the stock go up towards the…
Acadia Pharma Must Face Investors' Drug Approval Claims
Acadia Pharmaceuticals must face investors' class action claims it misstated the likelihood that it would get regulatory approval to market its psychosis drug pimavanserin for expanded use, a California federal judge... To view the full article…
Stock Market Today Live: Stock to buy today: Ajanta Pharma (₹3,073) - BUY
Sensex Today, Nifty 50 | Stock Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 11th June 2026 The short-term outlook is bullish for Ajanta Pharma. The stock is…
Heartland Advisors Inc. Grows Position in Royalty Pharma PLC $RPRX
Heartland Advisors Inc. boosted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 121.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 213,989 shares of…
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0710 GMT – AstraZeneca's data on its experimental obesity pill look surprisingly competitive, even if…
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO). In a filing disclosed on June 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in…
Job titles of the future: Nature's drug designer
In 2018, after nearly two decades working in Big Pharma, chemist Tim Cernak was ready to put his skills to a new use. For Merck, he'd developed precision therapies for cancer, HIV, and diabetes that could target disease while minimizing harm to…
Track Young Frontrunners In The 11th Edition Of The 30 Under 30 Asia List In Forbes
O pportunities often come unannounced. To the astute person who quickly acts upon them and plunges, as Goethe describes it, “boldly into the thick of life,” accrue the spoils. This edition is filled with examples of such risk-takers.
Indian Stock Market Falls: US-Iran Tensions, FII Outflows, US Inflation Impact Sensex, Nifty
Indian equity markets, including the Sensex and Nifty, experienced a downturn on Thursday, influenced by escalating US-Iran tensions, significant foreign fund outflows, and rising US inflation concerns. Indian benchmark indices, Sensex and Nifty…
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…
SpaceX's Healthcare Plays
In this week's edition of InnovationRx, we look at SpaceX's hopes for healthcare, the AI drug discovery startup Lilly and Pfizer are betting on, the greatest living immigrants in healthcare and more. To get it in your inbox, subscribe here.
From Sick Care to Healthcare
He breaks it down simply. “S stands for sales, I stands for innovation and T… many people will think T stands for technology… but actually it's talent.” Sales remains essential, he says, calling it “the…
Voters lean in favor of codifying Trump's MFN policy
Conducted by Democratic polling firm Lake Research Partners, the poll found drug pricing is high on the list of voters' priorities ahead of November's midterm elections. Nearly 6 in 10 voters said they believe prescription drug prices have not gone…
Receive a Daily briefing on Pharma Industry News
Get Started